Cohort 2:None

4 trials

Sponsors

Beijing Cancer Hospital, Harbin Medical University Cancer Hospital, Affiliated Hospital of Guilin Medical University, Hefei Fourth Peoples Hospital

Conditions

Cognitive impairmentDiffuse Large B-Cell and Mantle Cell LymphomaHepatocellular Carcinomanon-small cell lung cancer

Unknown Phase

Patient characteristics, treatment pattern and clinical outcomes of Diffuse Large B-Cell and Mantle Cell Lymphoma in China-PARADIGM

Active, not recruitingChiCTR2400087712

Beijing Cancer HospitalDiffuse Large B-Cell and Mantle Cell Lymphoma

Start: 2024-08-26Updated: 2024-08-05

A multicenter real-world clinical study on the efficacy and safety of Ensartinib as neoadjuvant treatment for anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC) patients.

Active, not recruitingChiCTR2400092080

Harbin Medical University Cancer Hospitalnon-small cell lung cancer

Start: 2024-12-01Updated: 2024-11-11

Impact of Emotional Stress on Immune Checkpoint Inhibitor Treatment Outcomes in Hepatocellular Carcinoma: A Multicohort Clinical Study

Active, not recruitingChiCTR2400094830

Affiliated Hospital of Guilin Medical UniversityHepatocellular Carcinoma

Start: 2024-12-31Updated: 2025-01-06

Role of ß-Hydroxybutyrate-Mediated Liver-Brain Axis in Metabolic Dysfunction-Associated Steatotic Liver Disease-Induced Cognitive Dysfunction and Novel Therapeutic Strategies

Active, not recruitingChiCTR2600128598

Hefei Fourth Peoples HospitalCognitive impairment

Start: 2026-07-22Updated: 2026-08-03